Given the importance of RLIP76 in classical apoptosis pathway and Rho signaling, it is also reasonable to speculate that agents specifically targeting RLIP76 could be beneficial in malignant meningioma patients. Here, RALBP1 is linked to Anaplastic (Malignant) Meningioma.